• 1
    Verhoeff AP & Burge HA. Health risk assessment of fungi in home environments. Ann Allergy Asthma Immunol 1997;78:544556.
  • 2
    Pasanen A-L, Niininen M, Kalliokoski P. Airborne Cladosporium and other fungi in damp versus reference residences. Atmospheric Environ 1992;1:121124.
  • 3
    Peat JK, Dickerson J, Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy 1998;53:120128.
  • 4
    Billings CG & Howard P. Damp housing and asthma. Monaldi Arch Chest Dis 1998;53:4349.
  • 5
    Husman T. Health effects of indoor-air microorganisms. Scand J Work Environ Health 1996;22:513.
  • 6
    D'Amato G, Spieksma F, Th M. Aerobiologic and clinical aspects of mould allergy in Europe. Allergy 1995;50:870877.
  • 7
    Bush RK. Fungal extracts in clinical practice. Allergy Proc 1993;14:385390.
  • 8
    Holt PG. Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model. Environ Health Perspectives 1999;107:485487.
  • 9
    Munir AKM & Björksten B. Health risk assessment of mould allergen exposure. Acta Paediatr 1997;86:11531154.
  • 10
    Taskinen T, Meklin T, Nousiainen M, Husman T, Nevalainen A, Korppi M. Moisture and mold problems in schools and respiratory manifestations in school-children: clinical and skin test findings. Acta Paediatr 1997;86:11811187.
  • 11
    Taskinen T, Hyvärinen A, Meklin T, Husman T, Nevalainen A, Korppi M. Asthma, atopy and respiratory infections in school-children with special reference to moisture and mold problems in the school. Acta Paediatr 1999;88:13731379.
  • 12
    Immonen J, Meklin T, Taskinen T, Nevalainen A, Korppi M. Skin prick test findings in students from moisture and mould damaged schools: a three-year follow-up study. Pediatr Allergy Immunol 2000;10:19.
  • 13
    Rylander R, Norrhall M, Engdahl U, Tunsäter A, Holt PG.. Airways inflammation, atopy, and (;1: – beta-d-glucan exposures in two schools. Am J Respir Crit Care Med 1998;158:16851687.
  • 14
    Rylander R & Lin R. (1–3)-beta-d-glucan relationship to indoor air-related symptoms, allergy and asthma. Toxicology 2000;152:4752.DOI: 10.1016/s0300-483x(00)00291-2
  • 15
    Douwes J, Wouters I, Dubbeld H, et al. Upper airway inflammation assessed by nasal lavage in compost workers: a relation with bio-aerosol exposure. Am J Ind Med 2000;37:459468.
  • 16
    Terho EO, Husman K, Vohlonen I, Mäntyjärvi RA. Serum precipitins against microbes in mouldy hay with respect to age, sex, atopy, and smoking of farmers. Eur J Resp Dis 1987;152:115121.
  • 17
    Erkinjuntti-Pekkanen R, Reiman M, Kokkarinen JI, Tukiainen HO, Terho EO. IgG antibodies, chronic bronchitis, and pulmonary function values in farmer's lung patients and matched controls. Allergy 1999;54:17.
  • 18
    Kurup VP, Mäntyjärvi RA, Terho EO, Ojanen TH, Kalbfleisch JH. Circulating IgG antibodies against fungal and actinomycete antigens in the sera of farmer's lung patients from different countries. Mycopathologia 1987;98:9199.
  • 19
    Lappalainen S, Pasanen A-L, Reiman M, Kalliokoski P. Serum IgG antibodies against Wallemia sebi and Fusarium species in Finnish farmers. Ann Allergy Asthma Immunol 1998;81:585592.
  • 20
    Seuri M, Husman K, Kinnunen H, et al. An outbreak of respiratory diseases among workers at a water-damaged building- a case report. Indoor Air 2000;10:138145.
  • 21
    Eduard W. Immunoglobulin G antibodies against moulds and actinomycetes as biomarkers of exposure in the work environment. Occup Hyg 1995;1:247260.
  • 22
    Lappalainen S, Lindroos O, Reijula K. Concentrations of airborne viable spores of fungi and. Actinomycetes in mold-damaged offices and schools. In: Bioaerosols, Fungi and Mycotoxins: Health effects, Assessment, Prevention, Control. Johanning, Albany: Eastern New York Occupational and Environmental Health Center, 1999, 616619.
  • 23
    Nevalainen A, Hyvärinen A, Halla-aho J, et al. Building moisture, mold and symptoms of school children-starting an intervention study. Proc Healthy Buildings 1997;1:227231.
  • 24
    Rylander R. Effects After Mold Exposure –Which Are the Causative Agents? In: Bioaerosols, Fungi and Mycotoxins: Health effects, Assessment, Prevention, Control. Johanning, Albany: Eastern New York Occupational and Environmental Health Center, 1999, 2832.
  • 25
    Hirvonen M-R, Ruotsalainen M, Roponen M, et al. Nitric oxide and pro-inflammatory cytokines in nasal lavage fluid associated with symptoms and exposure to mouldy building microbes. Am J Respir Crit Care Med 1999;160:19431946.
  • 26
    Meklin T, Taskinen T, Nevalainen A.Microbial characterization of four school buildings. Proceedings of the 7th Int Congress on Indoor Air Quality and Climate. July 21–26, Nagoya, Japan.1996;2:10831088.
  • 27
    Johansson SGO, Hourihane J, O' B, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 28
    Samson RA, Flannigan B, Flannigan ME, Verhoeff AP, Adan OCG, Hoekstra ES. Health implications of fungi in indoor environments. Air Quality Monographs 1994;2:531538.
  • 29
    Flannigan B & Morey PR (eds).Control of moisture problems affecting biological indoor air quality. ISIAQ- International Society of Indoor Air Quality and Climate1996.
  • 30
    Samson RA. Ecology, Detection and Identification Problems of Mould in Indoor Environments. In: Bioaerosols, Fungi and Mycotoxins: Health effects, Assessment, Prevention, Control. Johanning, Albany: Eastern New York Occupational and Environmental Health Center, 1999, 3337.
  • 31
    Pöysä L. Atopy in children with and without a family history of atopy. II. Skin reactivity. Acta Paediatr Scand 1989;78:902906.
  • 32
    Taskinen T, Laitinen S, Hyvärinen A, et al. Mold-specific IgE antibodies in relation to exposure and skin test data in school-children. Allergol Int 2001;50:239245.
  • 33
    Pasanen A-L. Airborne mesophilic fungal spores in various residential environments. Atmospheric Environ 1992;1:28612868.
  • 34
    Hyvärinen A, Reponen T, Husman T, Ruuskanen J, Nevalainen A. Characterizing mold problem buildings – concentrations and flora of viable fungi. Indoor Air 1993;3:337343.
  • 35
    Pasanen A-L, Kalliokoski P, Pasanen P, Salmi T, Tossavainen A. Fungi carried from farmers' work into farm homes. Am Ind Hyg Assoc J 1989;50:631633.
  • 36
    Thorn J & Rylander R. Airways inflammation and glucan in a rowhouse area. Am J Respir Crit Care Med 1998;157:17981803.
  • 37
    Verhoeff AP, Van Strien RT, Van Wijnen JH, Brunekreef B. Damp housing and childhood respiratory symptoms: the role sensitization to dust mites and molds. Am J Epidemiol 1995;141:103110.
  • 38
    Pirhonen I, Nevalainen A, Husman T, Pekkanen J. Home dampness, moulds and their influence on respiratory infections and symptoms in adults in Finland. Eur Respir J 1996;9:26182622.
  • 39
    Korppi M, Laitinen S, Taskinen T, Nevalainen A, Husman T. Mould specific immunoglobulin G antibodies in the child population. World congress of lung health and the 10th annual ERS congress, Florence, Italy, August 30- September 3, 2000. Eur Respir J Supplement 2000;31:129.
  • 40
    Reponen T, Nevalainen A, Jantunen M, Pellikka M, Kalliokoski P. Normal range criteria for indoor air bacteria and fungal spores in a subarctic climate. Indoor Air 1992;2:2631.
  • 41
    Pepys J. Immunopathology of allergic lung disease. Allergy 1973;3:122.
  • 42
    Koskinen O, Husman T, Hyvärinen A, Reponen T, Nevalainen A. Respiratory symptoms and infections among children in day-care center with mold problems. Indoor Air 1995;5:39.
  • 43
    Rylander R. Airborne (1–3)-β-d-glucan and airway disease in a day-care center before and after renovation. Arch Environ Health 1997;52:281285.
  • 44
    Immonen J, Laitinen S, Taskinen T, Nevalainen A, Korppi M. Mold-specific immunoglobulin E antibodies in primary school students: a 3-year follow-up study. Pediatr Asthma, Allergy Immunol 2000;14:101108.
  • 45
    Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999;159:6973.
  • 46
    Andersen P, Pedersen OF, Bach B, Bonde GJ. Serum antibodies and immunoglobulins in smokers and nonsmokers. Clin Exp Immunol 1982;47:467473.
  • 47
    Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust 1983;2:425429.